ABITRAM
gene geneOn this page
Also known as CG-8FLJ20457Simiate
Summary
ABITRAM (actin binding transcription modulator, HGNC:1364) is a protein-coding gene on chromosome 9q31.3, encoding Protein Abitram (Q9NX38). Actin-binding protein that regulates actin polymerization, filopodia dynamics and increases the branching of proximal dendrites of developing neurons.
Predicted to enable actin filament binding activity and actin monomer binding activity. Predicted to be involved in dendrite morphogenesis; regulation of actin filament polymerization; and regulation of filopodium assembly. Predicted to be located in growth cone. Predicted to be active in several cellular components, including dendrite; filopodium tip; and lamellipodium.
Source: NCBI Gene 54942 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- Clinical variants (ClinVar): 59 total — 1 likely-pathogenic
- GTEx eGene: eQTL in 27 tissues, sQTL in 6 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.18 (unconstrained)
- MANE Select transcript:
NM_017832 - Notable: 59 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:1364 |
| Approved symbol | ABITRAM |
| Name | actin binding transcription modulator |
| Location | 9q31.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CG-8, FLJ20457, Simiate |
| Ensembl gene | ENSG00000119328 |
| Ensembl biotype | protein_coding |
| OMIM | 620392 |
| Entrez | 54942 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 13 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
MANE Select: ENST00000322940
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 3: 3
ENST00000322940, ENST00000374624, ENST00000445175, ENST00000466200, ENST00000899979, ENST00000919245, ENST00000964591, ENST00000964592, ENST00000998348, ENST00000998349, ENST00001097226, ENST00001123745, ENST00001123746, ENST00001128382, ENST00001128383, ENST00001128384, ENST00001139172
RefSeq mRNA: 2 — MANE Select: NM_017832
NM_001410990, NM_017832
CCDS: CCDS6774, CCDS94453
Canonical transcript exons
ENST00000322940 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000805974 | 108935638 | 108935689 |
| ENSE00000805975 | 108936308 | 108936437 |
| ENSE00000805976 | 108939196 | 108939272 |
| ENSE00000805977 | 108939385 | 108939454 |
| ENSE00001860780 | 108939549 | 108940954 |
| ENSE00002078636 | 108934400 | 108934565 |
Expression profiles
Bgee: expression breadth ubiquitous, 287 present calls, max score 96.22.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.5280 / max 117.1167, expressed in 1770 samples.
Highest expression (Bgee): bronchial epithelial cell, tongue squamous epithelium, epithelium of bronchus, bronchus, hair follicle.
Genetic regulation across tissues (GTEx eQTL / sQTL)
ABITRAM is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 27 tissues and its splicing (sQTL) in 6 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 33 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Cells Cultured fibroblasts | eqtl | 5.2e-15 | -0.28 | 9:108934109:G:C |
| Skin Not Sun Exposed Suprapubic | eqtl | 1.2e-11 | -0.19 | 9:108943221:A:C |
| Muscle Skeletal | eqtl | 2.4e-10 | +0.14 | 9:108914840:T:C |
| Skin Sun Exposed Lower leg | eqtl | 7.2e-10 | -0.16 | 9:108943221:A:C |
| Whole Blood | eqtl | 1.0e-09 | +0.12 | 9:108916148:T:A |
| Adipose Subcutaneous | eqtl | 5.9e-08 | -0.20 | 9:108934109:G:C |
| Artery Aorta | eqtl | 1.2e-07 | -0.51 | 9:108986527:G:C |
| Artery Tibial | eqtl | 7.6e-07 | -0.34 | 9:108998922:G:A |
| Lung | eqtl | 2.5e-06 | -0.26 | 9:108986527:G:C |
| Thyroid | eqtl | 2.9e-06 | +0.17 | 9:108885484:C:T |
| Adipose Visceral Omentum | eqtl | 4.9e-06 | +0.20 | 9:108914840:T:C |
| Adipose Subcutaneous | sqtl | 2.0e-05 | -0.33 | 9:108966438:C:T |
| Nerve Tibial | eqtl | 3.2e-05 | +0.22 | 9:109055674:AC:A |
| Liver | eqtl | 8.6e-05 | -0.91 | 9:108869463:G:C |
| Testis | eqtl | 1.3e-04 | -0.14 | 9:109000645:C:T |
| Esophagus Gastroesophageal Junction | eqtl | 2.1e-04 | +0.22 | 9:108983817:T:G |
| Brain Cerebellum | eqtl | 2.5e-04 | -0.54 | 9:108962639:G:C |
| Breast Mammary Tissue | eqtl | 3.8e-04 | -0.18 | 9:108950644:G:C |
| Thyroid | sqtl | 7.2e-04 | +0.30 | 9:109120449:T:G |
| Heart Atrial Appendage | eqtl | 1.5e-03 | -0.44 | 9:108962639:G:C |
FANTOM5 promoters
1 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 97930 | 9.5280 | 1770 |
Top tissues by expression
showing 100 of 288 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 96.22 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 95.87 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 95.82 | gold quality |
| bronchus | UBERON:0002185 | 95.48 | gold quality |
| hair follicle | UBERON:0002073 | 94.55 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 93.79 | gold quality |
| secondary oocyte | CL:0000655 | 92.90 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 92.88 | gold quality |
| corpus epididymis | UBERON:0004359 | 92.79 | gold quality |
| caput epididymis | UBERON:0004358 | 92.56 | gold quality |
| gingival epithelium | UBERON:0001949 | 92.40 | gold quality |
| parotid gland | UBERON:0001831 | 91.86 | gold quality |
| squamous epithelium | UBERON:0006914 | 91.83 | gold quality |
| sperm | CL:0000019 | 91.80 | gold quality |
| gingiva | UBERON:0001828 | 91.73 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 91.61 | gold quality |
| male germ cell | CL:0000015 | 91.56 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 91.38 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 91.32 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 91.23 | gold quality |
| heart right ventricle | UBERON:0002080 | 91.15 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 90.90 | gold quality |
| right uterine tube | UBERON:0001302 | 90.73 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 90.71 | gold quality |
| oocyte | CL:0000023 | 90.70 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 90.38 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 90.33 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.30 | gold quality |
| colonic mucosa | UBERON:0000317 | 90.28 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 90.20 | gold quality |
| cardia of stomach | UBERON:0001162 | 90.03 | gold quality |
| vena cava | UBERON:0004087 | 89.80 | gold quality |
| cervix epithelium | UBERON:0004801 | 89.79 | gold quality |
| thyroid gland | UBERON:0002046 | 89.73 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 89.69 | gold quality |
| mammalian vulva | UBERON:0000997 | 89.62 | gold quality |
| cauda epididymis | UBERON:0004360 | 89.61 | gold quality |
| skin of leg | UBERON:0001511 | 89.05 | gold quality |
| skin of abdomen | UBERON:0001416 | 89.03 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 88.96 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 88.93 | gold quality |
| nucleus accumbens | UBERON:0001882 | 88.85 | gold quality |
| caudate nucleus | UBERON:0001873 | 88.79 | gold quality |
| putamen | UBERON:0001874 | 88.65 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 88.57 | gold quality |
| zone of skin | UBERON:0000014 | 88.38 | gold quality |
| pituitary gland | UBERON:0000007 | 88.30 | gold quality |
| superficial temporal artery | UBERON:0001614 | 88.24 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 88.19 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 88.11 | gold quality |
| esophagus mucosa | UBERON:0002469 | 88.08 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 88.06 | gold quality |
| rectum | UBERON:0001052 | 88.04 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 88.03 | gold quality |
| mammary duct | UBERON:0001765 | 87.92 | gold quality |
| oral cavity | UBERON:0000167 | 87.84 | gold quality |
| lower lobe of lung | UBERON:0008949 | 87.83 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 87.76 | gold quality |
| substantia nigra | UBERON:0002038 | 87.71 | gold quality |
| diaphragm | UBERON:0001103 | 87.69 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 87.65 | gold quality |
| adenohypophysis | UBERON:0002196 | 87.64 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 87.61 | gold quality |
| midbrain | UBERON:0001891 | 87.60 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 87.57 | gold quality |
| pons | UBERON:0000988 | 87.50 | gold quality |
| amniotic fluid | UBERON:0000173 | 87.44 | gold quality |
| spinal cord | UBERON:0002240 | 87.42 | gold quality |
| body of pancreas | UBERON:0001150 | 87.36 | gold quality |
| endometrium | UBERON:0001295 | 87.35 | gold quality |
| type B pancreatic cell | CL:0000169 | 87.23 | silver quality |
| jejunal mucosa | UBERON:0000399 | 87.22 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 87.18 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 87.16 | gold quality |
| left ovary | UBERON:0002119 | 87.14 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.11 | gold quality |
| uterine cervix | UBERON:0000002 | 87.10 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 87.07 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 87.07 | gold quality |
| tibial nerve | UBERON:0001323 | 86.99 | gold quality |
| penis | UBERON:0000989 | 86.87 | gold quality |
| vastus lateralis | UBERON:0001379 | 86.87 | gold quality |
| hypothalamus | UBERON:0001898 | 86.87 | gold quality |
| olfactory bulb | UBERON:0002264 | 86.87 | silver quality |
| esophagus | UBERON:0001043 | 86.85 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 86.84 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 86.82 | gold quality |
| forebrain | UBERON:0001890 | 86.81 | gold quality |
| biceps brachii | UBERON:0001507 | 86.78 | gold quality |
| endothelial cell | CL:0000115 | 86.77 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 86.70 | gold quality |
| telencephalon | UBERON:0001893 | 86.68 | gold quality |
| right ovary | UBERON:0002118 | 86.68 | gold quality |
| uterus | UBERON:0000995 | 86.67 | gold quality |
| right adrenal gland | UBERON:0001233 | 86.66 | gold quality |
| cingulate cortex | UBERON:0003027 | 86.66 | gold quality |
| body of uterus | UBERON:0009853 | 86.66 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 86.65 | gold quality |
| prefrontal cortex | UBERON:0000451 | 86.64 | gold quality |
| upper arm skin | UBERON:0004263 | 86.58 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.98 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 79 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Cerebral cortex | tissue | 25.4 | low |
| Occipital cortex | tissue | 25.4 | |
| Putamen | tissue | 24.7 | |
| Somatosensory cortex | tissue | 24.6 | |
| Epididymis | tissue | 23.7 | medium |
| Skin 1 | tissue | 23.0 | medium |
| Prefrontal cortex | tissue | 22.9 | |
| Basal ganglia | tissue | 22.9 | low |
| Retina | tissue | 22.8 | |
| Parathyroid gland | tissue | 21.8 | low |
| Motor cortex | tissue | 21.8 | |
| Hippocampal formation | tissue | 21.7 | |
| Temporal cortex | tissue | 20.6 | |
| Pons | tissue | 20.4 | |
| Ventral forebrain | tissue | 20.4 | |
| Choroid plexus | tissue | 20.3 | |
| Midbrain | tissue | 20.3 | |
| Postcentral gyrus | tissue | 20.3 | |
| Entorhinal cortex | tissue | 20.3 | |
| Thalamus | tissue | 20.2 | |
| Fallopian tube | tissue | 20.2 | not detected |
| Nucleus accumbens | tissue | 19.9 | |
| Superior colliculi | tissue | 19.9 | |
| Retrosplenial and cingulate cortex | tissue | 19.5 | |
| Testis | tissue | 18.9 | low |
| Medulla oblongata | tissue | 18.7 | |
| Septum | tissue | 18.6 | |
| Retrosplenial cortex | tissue | 18.3 | |
| Spinal cord | tissue | 18.2 | |
| Thyroid gland | tissue | 17.7 | not detected |
| Olfactory bulb | tissue | 17.7 | |
| Insular cortex | tissue | 17.1 | |
| Substantia nigra | tissue | 16.8 | |
| Periaqueductal gray | tissue | 16.5 | |
| Breast | tissue | 16.1 | medium |
| Hypothalamus | tissue | 15.6 | |
| Esophagus | tissue | 15.5 | low |
| Amygdala | tissue | 15.3 | |
| Rectum | tissue | 15.1 | medium |
| Pituitary gland | tissue | 15.0 | |
| Heart muscle | tissue | 14.7 | medium |
| Bone marrow | tissue | 14.7 | low |
| Locus coeruleus | tissue | 14.5 | |
| Salivary gland | tissue | 14.4 | low |
| Hippocampus | tissue | 14.0 | not detected |
| Colon | tissue | 13.9 | low |
| Stomach 1 | tissue | 13.7 | medium |
| Liver | tissue | 13.7 | medium |
| Corpus callosum | tissue | 13.6 | |
| Duodenum | tissue | 13.5 | medium |
| Seminal vesicle | tissue | 13.4 | medium |
| Adipose tissue | tissue | 13.3 | not detected |
| Cerebellum | tissue | 13.2 | low |
| Endometrium 1 | tissue | 12.7 | not detected |
| Kidney | tissue | 12.7 | low |
| Vagina | tissue | 12.5 | medium |
| Pancreas | tissue | 12.5 | medium |
| Skeletal muscle | tissue | 12.3 | medium |
| Small intestine | tissue | 12.3 | medium |
| Lung | tissue | 11.9 | low |
Brain sub-regions (HPA Brain Atlas): detected in 190; highest nTPM — Dorsal hippocampus (21.7), Ventral hippocampus (21.1), Temporo-occipital transitional zone (20.7), Subiculum (20.4), Caudate nucleus (19.9).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting ABITRAM by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 59 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-3682-5P | 99.93 | 67.97 | 1163 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-567 | 99.63 | 68.57 | 1219 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-4687-3P | 99.48 | 66.41 | 968 |
| HSA-MIR-3182 | 99.40 | 68.15 | 2454 |
| HSA-MIR-302A-5P | 99.39 | 68.21 | 1913 |
| HSA-MIR-2115-3P | 99.31 | 69.68 | 2026 |
| HSA-MIR-5582-5P | 99.27 | 71.42 | 1879 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-6739-3P | 99.22 | 68.84 | 1843 |
| HSA-MIR-548L | 99.06 | 70.90 | 2560 |
| HSA-MIR-129-1-3P | 98.86 | 68.41 | 779 |
| HSA-MIR-129-2-3P | 98.86 | 68.41 | 779 |
| HSA-MIR-6715B-3P | 98.80 | 68.07 | 1204 |
| HSA-MIR-4742-3P | 98.73 | 69.82 | 1803 |
Functional genomics
gnomAD constraint: pLI 8.06e-05, LOEUF 1.18, missense Z 0.191 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000322940 — one region, missense o/e 0.98.
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | abitram | ENSDARG00000070407 |
| mus_musculus | Abitram | ENSMUSG00000038827 |
| rattus_norvegicus | Abitram | ENSRNOG00000010532 |
| drosophila_melanogaster | CG9288 | FBGN0260464 |
| caenorhabditis_elegans | WBGENE00018835 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:2677850) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 4 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| abnormal retina vasculature morphology | 1 |
| increased cardiac muscle contractility | 1 |
| increased bone mineral content | 1 |
| decreased total retina thickness | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Pongo abelii | Q5RFS0 | 100.0% | Diamond |
| Xenopus tropicalis | Q28G67 | 90.2% | Diamond |
| Xenopus laevis | Q6GR35 | 90.2% | Diamond |
| Bos taurus | Q29S16 | 89.8% | Diamond |
| Gallus gallus | Q5ZHW7 | 80.8% | Diamond |
| Dictyostelium discoideum | Q54TD9 | 36.8% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| TMEM245 | protein-coding | 23731 |
| FRRS1L | protein-coding | 23732 |
| MIR32 | ncRNA | 407036 |
| ELP1 | protein-coding | 8518 |
| CTNNAL1 | protein-coding | 8727 |
| ACTL7B | protein-coding | 10880 |
| ACTL7A | protein-coding | 10881 |
| EPB41L4B | protein-coding | 54566 |
Protein
Protein identifiers
Protein Abitram — Q9NX38 (reviewed: Q9NX38)
Alternative names: Actin-binding transcription modulator, Protein Simiate
All UniProt accessions (3): Q9NX38, X6R8U7, X6REY2
UniProt curated annotations — full annotation on UniProt →
Function. Actin-binding protein that regulates actin polymerization, filopodia dynamics and increases the branching of proximal dendrites of developing neurons.
Subunit / interactions. Interacts with F-actin. Interacts with G-actin.
Subcellular location. Nucleus speckle. Cell projection. Lamellipodium. Nucleus. Growth cone. Dendrite.
Miscellaneous. Depletion of ABITRAM by siRNA or neutralizing antibodies results in cell death within a few hours.
Similarity. Belongs to the ABITRAM family.
RefSeq proteins (2): NP_001397919, NP_060302* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011053 | Single_hybrid_motif | Homologous_superfamily |
| IPR033753 | GCV_H/Fam206 | Family |
| IPR039169 | Abitram | Family |
Pfam: PF01597
UniProt features (1 total): chain 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NX38-F1 | 80.21 | 0.10 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, Plasma proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): cytosol; nucleoplasm; cytokinetic bridge; kinetochore; mitotic spindle; primary cilium; primary cilium tip
Antibody reliability (HPA): IH uncertain · IF approved
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 122 (showing top):
GOBP_DENDRITE_DEVELOPMENT, GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION, GOBP_NEUROGENESIS, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, GOBP_DENDRITE_MORPHOGENESIS, GOBP_ACTIN_FILAMENT_ORGANIZATION, GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY, GOMF_ACTIN_BINDING, GOCC_NEURON_PROJECTION, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_REGULATION_OF_CELL_PROJECTION_ASSEMBLY
GO Biological Process (3): regulation of actin filament polymerization (GO:0030833), dendrite morphogenesis (GO:0048813), regulation of filopodium assembly (GO:0051489)
GO Molecular Function (4): actin monomer binding (GO:0003785), actin filament binding (GO:0051015), actin binding (GO:0003779), protein binding (GO:0005515)
GO Cellular Component (6): nucleus (GO:0005634), nuclear speck (GO:0016607), lamellipodium (GO:0030027), dendrite (GO:0030425), growth cone (GO:0030426), filopodium tip (GO:0032433)
GO top-level categories
22 GO namespaces:
| Category | Terms |
|---|---|
| actin binding | 2 |
| regulation of actin polymerization or depolymerization | 1 |
| actin filament polymerization | 1 |
| regulation of protein polymerization | 1 |
| dendrite development | 1 |
| cell morphogenesis involved in neuron differentiation | 1 |
| neuron projection morphogenesis | 1 |
| filopodium assembly | 1 |
| regulation of plasma membrane bounded cell projection assembly | 1 |
| protein-containing complex binding | 1 |
| cytoskeletal protein binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear ribonucleoprotein granule | 1 |
| cell leading edge | 1 |
| plasma membrane bounded cell projection | 1 |
| neuron projection | 1 |
| dendritic tree | 1 |
| site of polarized growth | 1 |
| distal axon | 1 |
| filopodium | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
showing 15 of 577 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ABITRAM | FRRS1L | Q9P0K9 | 882 |
| ABITRAM | HSDL1 | Q3SXM5 | 512 |
| ABITRAM | CTNNAL1 | Q9UBT7 | 507 |
| ABITRAM | SPRYD7 | Q5W111 | 469 |
| ABITRAM | NIPAL3 | Q6P499 | 465 |
| ABITRAM | SERAC1 | Q96JX3 | 459 |
| ABITRAM | NIPAL1 | Q6NVV3 | 454 |
| ABITRAM | NHERF4 | Q86UT5 | 447 |
| ABITRAM | ZACN | Q401N2 | 445 |
| ABITRAM | TMEM245 | Q9H330 | 441 |
| ABITRAM | ELP1 | O95163 | 441 |
| ABITRAM | C8A | P07357 | 437 |
| ABITRAM | AMZ2 | Q86W34 | 433 |
| ABITRAM | LGALS8 | O00214 | 420 |
| ABITRAM | C8B | P07358 | 388 |
IntAct
Human interaction partners of ABITRAM in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
6 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| PUS10 | physical association | 0.740 | 6 |
| HMBOX1 | physical association | 0.720 | 6 |
| MESD | physical association | 0.560 | 3 |
| PGCKA1 | physical association | 0.560 | 3 |
| POTEF | association | 0.530 | 2 |
| FYN | association | 0.350 | 1 |
Disease & clinical
Genetic variants
Variant evidence for ABITRAM: 59 ClinVar records (1 pathogenic / likely pathogenic). Per-variant detail is on Sugi Variant.
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 45 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
Showing all 1 pathogenic / likely-pathogenic ClinVar records, ranked by ClinVar review status (expert panel → multiple submitters → single submitter), then by number of submitting labs.
| Variant ID | HGVS | Classification | Review | Submitters |
|---|---|---|---|---|
| 1527542 | GRCh37/hg19 9q31.2-32(chr9:109265628-117650999)x1 | Likely pathogenic | criteria provided, single submitter | 1 |
Per-variant reference — Sugi Variant
Explore ABITRAM’s pathogenic and likely-pathogenic variants individually — each with its ClinVar classification and conditions, applied ACMG criteria (ClinGen expert panel, where curated), the calibrated in-silico predictors (AlphaMissense, REVEL, SaProt, conservation), gnomAD frequency, and the predictor-disagreement QC signal — on Sugi Variant.
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 42 predictions of 419):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 9:108934566–108934567 | donor_loss | 1.0000 | 5 |
| 9:108939193 | acceptor_gain | 1.0000 | |
| 9:108939547–108939548 | acceptor_loss | 1.0000 | 4 |
| 9:108939194–108939195 | acceptor_loss | 0.9900 | 6 |
| 9:108939273–108939274 | donor_loss | 0.9900 | 5 |
| 9:108939383–108939384 | acceptor_loss | 0.9900 | 6 |
| 9:108939455–108939456 | donor_loss | 0.9900 | 6 |
| 9:108939547–108939548 | acceptor_loss | 0.9900 | 2 |
| 9:108936384 | donor_gain | 0.9800 | |
| 9:108936306–108936307 | acceptor_loss | 0.9700 | 6 |
AlphaMissense
552 missense substitutions predicted likely pathogenic (of 1,180 scored), across 125 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| H41 | 8 | 0.997 | 0.999 |
| D35 | 8 | 0.984 | 0.995 |
| N43 | 8 | 0.975 | 0.999 |
| H54 | 8 | 0.971 | 0.995 |
| N79 | 8 | 0.967 | 0.998 |
| N123 | 8 | 0.946 | 0.995 |
| F20 | 7 | 0.987 | 0.995 |
| E121 | 7 | 0.974 | 0.995 |
| F91 | 7 | 0.971 | 0.996 |
| Q90 | 7 | 0.962 | 0.994 |
| K86 | 7 | 0.961 | 1.000 |
| C99 | 7 | 0.948 | 0.998 |
| C46 | 7 | 0.933 | 0.997 |
| W23 | 7 | 0.921 | 0.970 |
| C74 | 7 | 0.881 | 0.974 |
| E152 | 7 | 0.869 | 0.973 |
| Q40 | 7 | 0.863 | 0.992 |
| C37 | 7 | 0.862 | 0.975 |
| D27 | 7 | 0.794 | 0.920 |
| G83 | 6 | 0.998 | 1.000 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
2 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Liver Hepatocellular Carcinoma (TCGA) | unfavorable | 0.000246 |
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 0.00031 |
Disease associations
OMIM: gene MIM:620392 | disease phenotypes:
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | increases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Vanadates | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
10 trials:
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01064505 | Phase 1 | COMPLETED | Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients |
| NCT05147701 | Phase 1 | RECRUITING | Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION |
| NCT02882477 | Phase 2/3 | UNKNOWN | Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy |
| NCT01834079 | Phase 1/2 | UNKNOWN | Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease |
| NCT04680143 | Phase 1/2 | COMPLETED | Systemic Erythropoietin Injection in Patients Having Optic Atrophy |
| NCT03011541 | Not specified | RECRUITING | Stem Cell Ophthalmology Treatment Study II |
| NCT04580979 | Not specified | COMPLETED | Natural History Study of FDXR Mutation-related Mitochondriopathy |
| NCT04594590 | Not specified | COMPLETED | Natural History Study of SLC25A46 Mutation-related Mitochondriopathy |
| NCT04723160 | Not specified | COMPLETED | Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph |
| NCT06390579 | Not specified | COMPLETED | Building Research With Artificial Intelligence in Neuro-Ophthalmology |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): optic atrophy